arrow
K

Kenner C. Rice

national institute on drug abuse
H指数:85
被引数:3.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Novel 5-Phenylmorphans as Opioid Receptor Antagonists: Synthesis, Structure-Activity Relationship, Biological Evaluation and Computational Modeling

新型5-苯基吗啡烷作为阿片受体拮抗剂:合成、构效关系、生物评价和计算建模

2026-10-020
OA
Author Correction: A µ-opioid receptor superagonist analgesic with minimal adverse effects

作者更正:一种具有最小不良反应的μ-阿片受体超激动剂镇痛药

Nature
IF48.5
2026-04-240
OAAI
A µ-opioid receptor superagonist analgesic with minimal adverse effects

一种具有最小不良反应的μ-阿片受体超激动剂镇痛药

Nature
IF48.5
2026-04-010
OA
Transformation of a Potent C9-Substituted Phenylmorphan into MOR Partial Agonists with Improvement of Metabolic Stability: An In Vitro, In Vivo, and In Silico Study

将一种强效C9-取代的苯基吗喃转化为MOR部分激动剂并提高代谢稳定性:一项体外、体内和计算机模拟研究

2025-05-200
PRE
Cardiovascular and locomotor effects of binary mixtures of common 'bath salts' constituents: Studies with methylone, methylenedioxypyrovalerone and caffeine in rats

二元混合物中常见“浴盐”成分的心血管和运动效应:甲基酮、亚甲二氧基吡咯戊酮和咖啡因在鼠中的研究

2025-01-220
PRE
Potent MOR Agonists from 2′-Hydroxy-5,9-dimethyl-N-phenethyl Substituted-6,7-benzomorphans and from C8-Hydroxy, Methylene and Methyl Derivatives of N-Phenethylnormetazocine

来自2 ′-Hydroxy-5,9-二甲基-N-苯乙基取代的-6,7-苯并吗啉和N-苯乙基去甲甲佐辛的C8-Hydroxy,亚甲基和甲基衍生物的有效MOR激动剂

2023-11-221
OAAI
Initial Pharmacological Characterization of a Major Hydroxy Metabolite of PF-5190457: Inverse Agonist Activity of PF-6870961 at the Ghrelin Receptor(SIC)
2023-08-017
OAAI